Khorana, Alok A. http://orcid.org/0000-0002-9509-0998
Mackman, Nigel
Falanga, Anna http://orcid.org/0000-0002-5007-3457
Pabinger, Ingrid
Noble, Simon
Ageno, Walter
Moik, Florian
Lee, Agnes Y. Y. http://orcid.org/0000-0003-1915-6681
Article History
Accepted: 6 January 2022
First Online: 17 February 2022
Competing interests
: A.A.K. received honoraria from Janssen, Bayer, BMS, Pfizer, Sanofi, Anthos and Halozyme. N.M. received a research grant from GSK. W.A. received honoraria from Bayer, Portola, Sanofi, Aspen, Norgine, Leo Pharma and BMS-Pfizer, and research support from Bayer. S.N. received honoraria for delivering lectures from Leo Pharma, BMS-Pfizer Alliance, and grant support from Leo Pharma. A.F. was a speaker at corporate symposia (Bayer, Sanofi, Pfizer, Leo Pharma), and participated on advisory boards (Bayer, Sanofi). A.Y.Y.L. received honoraria from Bayer, BMS-Pfizer, Leo Pharma, Pfizer and Servier, and research support from BMS. I.P. received honoraria from Bayer, BMS, Pfizer, Sanofi and Daiichi Sanchyo. F.M. declares no competing interests.